Regulatory Open Forum

 View Only
  • 1.  Pediatric Study Plan

    Posted 05-Apr-2013 17:15
    Hello,
    We have been asked by FDA to prepare a Pediatric Study Plan at the end-of-phase 2 meeting.  Because we have no experience with it, I would appreciate some information on how to prepare this Pediatric Study Plan.
    Thanks,
    Best regards,
    Clarisse 

    -------------------------------------------
    Clarisse Stone RAC
    Manager, Electronic Documents
    Galderma R&D
    Cranbury NJ
    United States
    -------------------------------------------


  • 2.  RE:Pediatric Study Plan

    Posted 05-Apr-2013 17:46

    See these links on FDA's website:

    Pediatric Research Equity Act (PREA)

    Pediatric Study Plan Template (PDF - 23KB)11

    PREA Retrospective Review (PDF - 281KB)12
    1/14/2010

    Pediatric Research Equity Act of 2003 (Public Law No: 108-155) (posted 12/16/2003) (PDF - 50KB)13

    Guidance for Industry (Draft): How to Comply with the Pediatric Research Equity Act (posted 9/7/2005) (PDF - 116KB)14


    ______________________________________________
    Michael A. Swit, Esq.
    Special Counsel, FDA Law Practice
    Duane Morris LLP
    750 B Street, Suite 2900
    San Diego, CA 92101-4681
    P: +1 619 744 2215
    F: +1 619 923 2648
    C +1 760 815 4762
    maswit@duanemorris.com

    Note: all postings by me on this forum represent my personal views and are not necessarily those of my clients or my law firm. Further, my comments are not intended as legal advice but as the sharing of general knowledge and do not create an attorney-client relationship with any reader.

    Please follow me on LinkedIN and Twitter:
    http://www.linkedin.com/in/michaelswit
    https://twitter.com/FDACounsel

    -------------------------------------------








  • 3.  RE:Pediatric Study Plan

    Posted 05-Apr-2013 20:16
    As for the pediatric study plan, it is pursuant to BPCA ('02), PREA ('03), and FDASIA ('12).

    Under PREA, pediatric studies are required.
    Under BPCA, pediatric studies are optional/voluntary.  
    Under FDASIA, new requirements for pediatric study plan.

    Under FDASIA, sponsors are required to submit a PSP (Pediatric Study Plan) at the end of Phase 2.

    I have compiled some additional information on the subject.  Read more here >>

    ----------------------------------------------------------------------------------------
    Dr. David Lim, Ph.D., RAC, ASQ-CQA
    President and CEO ' Regulatory Doctor
    3955 Riner Road, Box #148
    Riner, VA 24149
    Phone: (540) 315-RAC1 (7221)
    E-mail:  RegulatoryDoctor@gmail.com
    Fax: (866) 591-5671

    **: Regulatory Doctor helps global healthcare industry "PASS-IT."

    **To contact or schedule time for an appointment:
    http://my.vcita.com/regulatorydr

    **For regulatory coaching and consulting:
    http://www.RegulatoryDoctor.com

    **For training and seminars:
    http://www.GlobalComplianceSeminar.com

    **To connect with me on LinkedIn:
    http://www.linkedin.com/in/fda510ksubmissionconsultant

    **To follow me on Twitter:
    https://twitter.com/RegulatoryDr

    I am using the power of vCita.  To learn more about vCita, please click here.  

    "Knowledge is power only when it is practiced and put into action." - Regulatory Doctor

    NOTICE: This communication (including any attachments) may contain privileged or confidential information intended for a specific individual and purpose, and is protected by law. If you are not the intended recipient, you should delete this communication and/or shred the materials and any attachments and are hereby notified that any disclosure, copying or distribution of this communication, or the taking of any action based on it, is strictly prohibited.